NEW YORK, April 16 - The bearish winds on Wall street have blown shut the doors to the capital markets, which means genomics companies will have to make do -- or perish -- with the funds they have raised so far, buy-side fund managers said Monday.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: global genetic diversity map, and more.
The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.
In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."
Stat News reports that there's muted opposition to the Kuwaiti DNA database law.